Evaluation of sexual function in patients presenting with Behçet’s disease with or without depression

Gül, Işıl Göğcegöz; Kartalcı, Şükrü; Cumurcu, Birgül Elbozan; Karincaoglu, Yelda; Yoloğlu, Saim; Karlidağ, Rıfat

doi:10.1111/j.1468-3083.2012.04698.x

Cited by 14 publications

(13 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Erythrocyte sedimentation rate9,16,22,24,34,40,43,47,49,59,60,61,63,66,67,68,69,76,77,85,89,94,139,143,177,220,228 and C-reactive protein9,16,24,40,43,47,49,59,60,66,67,76,77,85,89,94,143,177,216,220,228 levels were used as indicators of disease activity. No laboratory measure has been validated as a biomarker of disease activity in BS.…”

Section: Resultsmentioning

confidence: 99%

“…Several generic measures were used to evaluate the QOL and psychological, cognitive, or sexual effect of BS (Table 3)10,17,19,23,46,57,60,124,125,128,141,151,207,208,228-241,255,256. Among these, only the oral health-related QOL was specifically validated for BS 128 .…”

Section: Resultsmentioning

confidence: 99%

“…None of the RCT reported death. Life impact was addressed by 1 BS specific measure, Behçet Disease Quality of Life 19,124,125 , and several generic measures given in Table 3 10,17,19,23,46,57,60,124,125,128,141,151,207,208,228-241,255,256. There was 1 cost analysis study in BS that retrospectively analyzed direct costs such as medication, diagnostic tests, hospital visits, hospitalization fees, and lodging and transportation expenses and indirect costs such as lost workdays and wages by questioning the patients 242 .…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review

Hatemi

Merkel²,

Hamuryudan³

et al. 2014

J Rheumatol

View full text Add to dashboard Cite

Behçet syndrome (BS) is a multisystem vasculitis that is most active during young adulthood, causing serious disability and significant impairment in quality of life. Differences in the disease course, severity, and organ involvement between patients, depending on the age at presentation and sex, makes it impossible to determine a single management strategy. The diversity and variability in the outcome measures used in clinical trials in BS makes it difficult to compare the results or inform physicians about the best management strategy for individual patients. There is a large unmet need to determine or develop validated outcome measures for use in clinical trials in BS that are acceptable to researchers and regulatory agencies. We conducted a systematic review to describe the outcomes and outcome measures that have been used in clinical trials in BS. This review revealed the diversity and variability in the outcomes and outcome measures and the lack of standard definitions for most outcomes and rarity of validated outcome tools for disease assessment in BS. This systematic literature review will identify domains and candidate instruments for use in a Delphi exercise, the next step in the development of a core set of outcome measures that are properly validated and widely accepted by the collaboration of researchers from many different regions of the world and from different specialties, including rheumatology, ophthalmology, dermatology, gastroenterology, and neurology.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review

Hatemi

Merkel²,

Hamuryudan³

et al. 2014

J Rheumatol

View full text Add to dashboard Cite

show abstract

“…Çalışmamızda BH bulunan kadınlarda cinsel disfonksiyon oranı %81,8 olup literatür ile benzer şekilde BH olan kadınlarda KCFİ ortalama puanının sağlıklı kontrollere göre anlamlı şekilde düşük bulunmuştur (7,9). Behçet hastaları ile yapılan çalışmalarda hastalık sonrası dönemde cinsel yaşantının ve cinsel doyumun olumsuz yönde etkilendiği bildirilmiştir (6,22). Özdemir ve ark.…”

Section: Discussionunclassified

“…kadın Behçet hastalarında cinsel disfonksiyon oranını %89,8 olarak rapor etmişken (6) Gül ve ark. bu oranı %96,2 olarak bildirmişlerdir (22). Çalışmamızdan ve literatürden elde edilen veriler doğrultusunda kadın cinsiyet sebebi ile mevcut olan cinsel disfonksiyon riskinin BH sebebi ile hemen hemen ikiye katlandığı söylenebilir.…”

Section: Discussionunclassified

Kadın Behçet Hastalarında Cinsel Fonksiyonların Değerlendirilmesi

Erturan¹,

Atay²,

Oksay³

et al. 2014

tdd

View full text Add to dashboard Cite

Amaç: Bu çalışmanın amacı kadınlarda Behçet hastalığının (BH) cinsel fonksiyonlar üzerine etkisi ve cinsel fonksiyonların yaşam kalitesi ve depresyon seviyeleri ile ilişkisini araştırmaktır. Yöntem: Çalışmaya Behçet hastalığı olan 33 kadın hasta ve 37 sağlıklı kadın dahil edilmiştir. Her iki gruba da Sosyodemografik Veri Formu, Kadın Cinsel Fonksiyon İndeksi (KCFİ), Beck Depresyon Ölçeği (BDÖ) ve dermatolojik hastalıklar için hazırlanmış Yaşam Kalite Ölçeği (YKÖ) uygulanmıştır. Bulgular: Hasta grubunda yaş ortalaması 37,30±8,44 (20-47) yıl ve sağlıklı kontrollerde 37,54±7,62 (22-48) yıl olup her iki grup arasında anlamlı fark yoktu (p=0,902). Cinsel disfonksiyon oranı hasta grubunda (%81,8) sağlıklı kontrol grubuna (%45,9) göre anlamlı şekilde daha yüksekti (p=0,002). Toplam KCFİ ve alt parametrelerinin (cinsel arzu, uyarılma, lubrikasyon) puan ortalaması Behçetli hasta grubunda kontrollere göre anlamlı şekilde daha düşüktü. Behçet hasta grubunda BDÖ puanı ile kadın cinsel fonksiyonları ve dermatolojik yaşam kalitesi arasında negatif yönde anlamlı şekilde ilişki mevcuttu. Sonuç: Bu çalışmada Behçet hasta grubunda cinsel disfonksiyon görülme sıklığının sağlıklı kontrollere göre anlamlı şekilde daha yüksek olduğu sonucuna varılmıştır. Kadın Behçet hastalarında depresyonun bulunmasının yaşam kalitesi ve cinsel fonksiyonlar üzerinde olumsuz etkileri olduğunu düşünmekteyiz.

show abstract

Structured review of the use of the Arizona sexual experiences scale in clinical settings

Elnazer

Baldwin

2020

Human Psychopharmacology

View full text Add to dashboard Cite

Background: Approximately 40% of women and 30% of men describe sexual dysfunction, although recognition in medical settings is suboptimal, due to problems in reporting and eliciting concerns relating to sexual function and satisfaction. Screening questionnaires may help to support this aspect of clinical practice. The Arizona sexual experiences scale (ASEX) includes items that quantify sex drive, arousal, vaginal lubrication or penile erection, ability to reach orgasm, and satisfaction from orgasm. Method: We investigated the validity and other psychometric properties of the ASEX, and the findings from the populations in which it has been employed, by searching MEDLINE, EMBASE, and Google Scholar using the terms, Arizona sexual experiences scale, Arizona Sexual Experience Questionnaire, and ASEX. We eliminated duplications, letters, and papers not available in English, and grouped the remaining papers into the categories of psychometric, epidemiological, and outcomebased studies. Results: After elimination of letters and duplicates, papers not in English, and preclinical and irrelevant studies, 104 papers were analyzed. The ASEX has excellent internal consistency, scale reliability and strong test-retest reliability. Analyses of variance reveal significant differences in total ASEX scores between patients and controls and between females and males. ASEX appears to be useful in a range of clinical situations including patients with primary sexual dysfunction, specific psychiatric disorders, specific physical illnesses, and treatment emergent sexual dysfunction. Discussion: The ASEX appears to be a reliable instrument for identifying and quantifying sexual dysfunction across a range of populations in various clinical settings. Little is known about its utility in patients with anxiety disorders or relationships between ASEX scores and biological parameters.

show abstract

Evaluation of sexual function in patients presenting with Behçet’s disease with or without depression

Cited by 14 publications

References 21 publications

Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review

Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review

Kadın Behçet Hastalarında Cinsel Fonksiyonların Değerlendirilmesi

Structured review of the use of the Arizona sexual experiences scale in clinical settings

Contact Info

Product

Resources

About